Lower doses mean fewer side effects, lower costs (for compounded), and more room to increase if results plateau later
About this article Cite this article Li, Y., Xue, K., Hu, R
But I felt naked without my protective fat
Abstract Introduction Once-weekly semaglutide 1 mg is a novel glucagon-like peptide 1 receptor agonist (GLP-1 RA) that, in the SUSTAIN clinical trials, has demonstrated greater reductions in glycated haemoglobin (HbA1c) and body weight than the other GLP-1 RAs exenatide extended-release (ER) 2 mg, dulaglutide 1.5 mg and liraglutide 1.2 mg
Here are some potential options: Semaglutide : As mentioned earlier, semaglutide is another GLP-1 receptor agonist that can help with both blood sugar control and weight loss